Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Active filters
Reactivities
- Human
Assay Types
- Indirect
Filter by
Category
Target Symbol
- H3C1 (36)
- MAPT (24)
- NPPA (22)
- POMC (20)
- PDYN (18)
- EDN1 (15)
- GCG (14)
- PENK (14)
- PTH (13)
- CALCA (10)
- MUC1 (10)
- ADCYAP1 (9)
- H4-16 (9)
- TNF (9)
- AGT (8)
- AVP (8)
- CCR5 (8)
- APP (7)
- CD4 (7)
- EGFR (7)
- IAPP (7)
- SST (7)
- TAC1 (7)
- CD52 (6)
- IGF1 (6)
- INS (6)
- MSLN (6)
- VEGFA (6)
- VIP (6)
- ADM (5)
- CD80 (5)
- CORT (5)
- CRH (5)
- ERBB2 (5)
- GAL (5)
- GAST (5)
- GHRH (5)
- GHRL (5)
- GNRH1 (5)
- H3-3A (5)
- NMU (5)
- AOC3 (4)
- BLM (4)
- CD44 (4)
- FN1 (4)
- GRP (4)
- IL2RA (4)
- INSR (4)
- ITGB2 (4)
- NOTCH2 (4)
- PTHLH (4)
- PXN (4)
- TNFRSF8 (4)
- TOR2A (4)
- BOMBESIN (3)
- CALCB (3)
- CCK (3)
- CD40 (3)
- DNMT3A (3)
- GIP (3)
- H-PHE-MET-ARG-PHE-NH2 (3)
- H2BC5 (3)
- HCRT (3)
- HRCT (3)
- ITGA5 (3)
- KISS1 (3)
- KNG1 (3)
- LEY (3)
- NPPB (3)
- NPPC (3)
- NPY (3)
- NTS (3)
- OXT (3)
- PPY (3)
- PYY (3)
- SLC3A2 (3)
- TYRP1 (3)
- UTS2 (3)
- ACKR1 (2)
- ADRB2 (2)
- AGER (2)
- AKT1 (2)
- ALBUMIN (2)
- ANGIOTENSIN A (2)
- APLN (2)
- ARHGAP22 (2)
- BAGE (2)
- BGLAP (2)
- C3AR1 (2)
- C5AR1 (2)
- CALCITONIN N-TERMINAL FLANKING PEPTIDE (2)
- CD1A (2)
- CD28 (2)
- CD40LG (2)
- CD55 (2)
- CD74 (2)
- CD81 (2)
- CHGA (2)
- CR1 (2)
- CYSTATIN C (2)
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (40)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (9)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Families
- Druggable Genome (58)
- Transcription Factors (18)
- Secreted Protein (6)
- ES Cell Differentiation/IPS (4)
- Induced pluripotent stem cells (3)
- Transmembrane (3)
- Embryonic stem cells (2)
- Nuclear Hormone Receptor (2)
- Stem cell - Pluripotency (2)
- Protease (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
Pathways
- Systemic lupus erythematosus (52)
- Alzheimer's disease (24)
- MAPK signaling pathway (24)
- Pathways in cancer (7)
- Acute myeloid leukemia (5)
- Cysteine and methionine metabolism (5)
- Metabolic pathways (5)
- Cytokine-cytokine receptor interaction (3)
- PPAR signaling pathway (3)
- Adipocytokine signaling pathway (2)
- Jak-STAT signaling pathway (2)
- Neuroactive ligand-receptor interaction (2)
- Base excision repair (1)
- Bladder cancer (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Huntington's disease (1)
- Lysine degradation (1)
- NOD-like receptor signaling pathway (1)
- RIG-I-like receptor signaling pathway (1)
- RNA degradation (1)
- Thyroid cancer (1)
- Tight junction (1)
- Toll-like receptor signaling pathway (1)
- Ubiquitin mediated proteolysis (1)
- Vascular smooth muscle contraction (1)
- Viral myocarditis (1)